Reyes JAE, González GJ, Landgrave GI, Castro DLJ, Pérez GAC, Espinosa LFR

Idioma: Español
Referencias bibliográficas: 33
Paginas: 461-467
Archivo PDF: 269.31 Kb.

RESUMEN

Aunque los eosinófilos son componentes normales de los pulmones, diversos síndromes pulmonares eosinofílicos se distinguen por aumento de eosinófilos en sangre periférica, tejido pulmonar, esputo o en el lavado bronquioalveolar. Los síndromes pulmonares eosinofílicos generalmente se caracterizan por síntomas respiratorios, alteraciones en la radiografía y el potencial para manifestaciones sistémicas. Como el eosinófilo juega un papel tan importante en cada uno de estos síndromes, a menudo es difícil distinguir entre ellos. Sin embargo, existen diferencias clínicas importantes y paradigmas en el tratamiento; es importante entender y apreciar los rasgos que distinguen a cada una de estas condiciones. El presente artículo resume las manifestaciones clínicas de estos síndromes, sus diferencias y el abordaje diagnóstico del paciente con eosinofília y enfermedad pulmonar.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.

2. Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol 2007;119:1291-300.

3. Loffler W. Zur differential-diagnose der lungeninfiltriemungen. II. Uber fluchtige succedan-infiltrate (mit eosinophilie). Beitr Klin Tuberk 1932; 79:368-92.

4. Allen JN, Magro CM, King MA. The eosinophilic pneumonias, Sem in Resp and Crit Care Med 2002; 2(23):127-34.

5. Allen J. Eosinophilic lung diseases. (online) 2004; En: http://www.chestnet.org/education/online/pccu/vol 18/lesson 13-14/lesson 14.php

6. Badesch DB, King TE, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon. Am Rev Respir Dis 1989;139:249-52.

7. Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989;321:569-74.

8. Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. The Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMO’P). Am J Respir Crit Care Med 2002;166:1235-9.

9. Goetzl E, Luce J. Eosinophilic lung diseases. En: Murray J, Nadel J. Textbook of Respiratory Medicine. Filadelfia: Saunders 2000: 1757-73.

10. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005;60:841-57.

11. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969;280:787–98.

12. Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 1988;67:154-62.

13. Arakawa H, Kurihara Y, Niimi H, et al. Bronchiolitis obliterans with organizing pneumonia versus chronic eosinophilic pneumonia: high-resolution CT findings in 81 patients. Am J Roentgenol 2001;176:1053-8.

14. Marchand E, Reynaud-Gaubert M, Lauque D, et al. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe ’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERMO’P). Medicine (Baltimore) 1998;77:299-312.

15. Eric Marchand and Jean-François Cordier. Orphanet Journal of Rare Diseases 2006, 1:11

16. Churg J, Strauss L. Allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277-301.

17. Martin RM, Wilton LV, Mann RD. Prevalence of Churg–Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999; 8:179-89.

18. Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005;19:191-207.

19. Hattori N, Ichimura M, Nagamatsu M, et al. Clinicopathological features of Churg–Strauss syndrome-associated neuropathy. Brain 1999;122:427-39.

20. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg- Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33(8):1094-100.

21. Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1983;63:65-81.

22. Guillevin L, Cohen P, Gayraud M, et al. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37.

23. Conron M, Beynon HLC. Churg-Strauss syndrome. Thorax 2000;55:870-7.

24. Hagen EC, Daha MR, Hermans J, et al. The diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998;53:743-53.

25. Choi YH, Im JG, Han BK, et al. Thoracic manifestations of Churg-Strauss syndrome. Chest 2000;117:117-24.

26. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA1998; 279:455-7.

27. Wechsler ME, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-13.

28. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423-38.

29. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006;117:1292-302.

30. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54(1):1-27.

31. Klion AD. Recent advances in the diagnosis and treatment of hypereosinophilic syndromes. Hematology 2005;209-14.

32. Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy 2005;60:841-57.

33. Roufosse F, Cogan E, Goldman M. Recent advances in the pathogenesis and management of hypereosinophilic syndromes. Allergy 2004;59:673-89.